On this page of StockholderLetter.com we present the 7/21/2023 shareholder letter from PSYCHEMEDICS CORP — ticker symbol PMD. Reading current and past PMD letters to shareholders can bring important insights into the investment thesis.
PMD 7/21/2023 Shareholder/Stockholder Letter Transcript:
202 ANNUAL REPORT CORPORATE PROFILE Psychemedics is the pioneer and global leader of testing for drugs of abuse using hair analysis. With over 30 years of continuous innovation, Psychemedics is the only company to develop and patent a process that releases virtually 100% of ingested drugs from the inside of the hair. We believe Psychemedics superior science delivers the most sensitive FDA 510 K cleared tests in the world resulting in unmatched detection rates. Psychemedics results, science, and people are trusted by the world s most safety sensitive industries, the largest law enforcement agencies as well as by schools and elite institutions around the globe. The most recognized companies in the Fortune 500 rely on Psychemedics to ensure they are building drug free, safe, and productive workforces. We make businesses, our nation s highways, and campuses safe. Psychemedics quite literally invented the science that re-invented an industry. We are the standard against which all others measure themselves for sensitivity, quality, and innovation to stay ahead of the ever-changing illicit drug landscape.7/21/2023 Letter Continued (Full PDF)